Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Marinus ( (MRNS) ).
Marinus Pharmaceuticals has announced a Senior Management Retention Plan and an Amended and Restated Change in Control Severance Plan. These plans aim to retain senior management during strategic transactions and provide severance payments in case of employment termination following a change in control.
More about Marinus
Marinus Pharmaceuticals, Inc. is a company in the pharmaceutical industry focused on developing innovative treatments. They are exploring strategic alternatives to maximize shareholder value.
YTD Price Performance: -97.88%
Average Trading Volume: 2,694,852
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $12.69M
For an in-depth examination of MRNS stock, go to TipRanks’ Stock Analysis page.